Developer docs
API playgroundTry for free, no card

Search company profiles

duchenneconnect

Full company profile

uuid02m573d

Namestring
duchenneconnect
Legal namestring
Parent Project Muscular Dystrophy
Company typeenum
Private
Founded yearint
2007
Descriptiontext

DuchenneConnect (operating as The Duchenne Registry) is a nonprofit patient-reported registry founded in 2007 and operated by Parent Project Muscular Dystrophy (PPMD) that serves individuals with Duchenne and Becker muscular dystrophy, female carriers, and others with pathogenic Duchenne gene variants. Participants self-register through a mobile app (iOS and Android, launched 2019 via THREAD Research) and a web portal, then complete longitudinal surveys covering muscle strength, cardiac health, medications, and treatments. As of the 15-year report, the registry held approximately 5,500 registrants across more than 125 countries, with data used in 13+ peer-reviewed publications and connected to 175+ clinical trials and research studies.

The registry's core technology layer consists of three components: the THREAD Research-hosted mobile/web participant platform, the Prometheus Research (an IQVIA company)-managed Duchenne Outcomes Research Interchange data warehouse, and bidirectional EHR integration with PPMD's Certified Duchenne Care Centers (CDCCs). This architecture combines patient-reported data, clinical EHR data, and data from industry partners with approved therapies into a unified longitudinal natural history dataset. Data is also contributed to TREAT-NMD's international pooled registry and the Duchenne Regulatory Science Consortium (D-RSC) at the Critical Path Institute.

The business model is grant- and donation-funded rather than commercial. PPMD has been the sole institutional funder since 2011, covering all operating costs. Participation is free for patients and families, with no pricing tiers. De-identified data is shared with researchers and pharmaceutical companies on a research-collaboration basis rather than through paid licensing, although the registry reserves the right to charge for services in the future. The customer base is therefore split between patient/caregiver participants (no cost) and industry/academic data consumers (collaborative access), with the Duchenne Drug Development Roundtable (DDDR) serving as the industry advisory channel.

Short descriptiontext

The Duchenne Registry is a free, patient-reported mobile and web registry for individuals with Duchenne and Becker muscular dystrophy and female carriers, operated by Parent Project Muscular Dystrophy since 2007 and combining 15 years of longitudinal self-reported data with EHR data from Certified Duchenne Care Centers.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersHackensack, United States
HQ citystring
Hackensack
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
patient registry platform, rare disease research, clinical trial recruitment, natural history data, genetic testing program
Industry2 codes
PRIMARYHLACAHAH
Patient Registries & Chronic Disease Registry Analytics
Healthcare & Life Sciences/Digital Health & Health IT/Population Health Management & Value-Based Care Analytics
SECONDARYHLAJAJAE
Disease Registries (Cancer, Immunization, Rare Disease, etc.)
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Statistics, Vital Records & Population Health Analytics
Product category
Patient Registry Platform
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Research Grants and Institutional Funding
TypeSubscription Recurring
Description

The Duchenne Registry has been funded entirely by Parent Project Muscular Dystrophy (PPMD) since 2011. PPMD funds the registry through institutional budgets and grants. Data is shared with researchers and pharmaceutical companies (de-identified) to advance Duchenne research. Participation is free for patients. Registry services are provided at no cost to registrants.

duchenneregistry.org
2Data Licensing to Industry Partners
TypeData Monetisation
Description

De-identified registry data is shared with researchers, pharmaceutical companies, and the Duchenne Regulatory Science Consortium (D-RSC) at the Critical Path Institute to support drug development and clinical trials. This is done on a research collaboration basis, not a commercial transaction.

duchenneregistry.org
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Others
Pricing details1 tier
1Free Patient Participation
ModelFreemiumBilling cadenceFree
Notes

Registration and participation in The Duchenne Registry is free for all patients and families. There is no cost to join, complete surveys, or access the mobile app or web portal.

duchenneregistry.org
GTM typeB2C
B2C
Offering typeSoftware
Software
Brand1 record
1Duchenne Outcomes Research Interchange
Description

A patient- and clinician-reported data warehouse combining data from The Duchenne Registry with Electronic Health Record data and industry partner data.

duchenneregistry.org
Core offering1 text field

The Duchenne Registry is a patient-reported data registry for individuals with Duchenne or Becker muscular dystrophy and female carriers, accessible via mobile app (iOS and Android) and web portal. Participants self-register, complete medical surveys on muscle strength, cardiac health, medications, and treatments, and contribute longitudinal health data that is shared (de-identified) with researchers, drug developers, and the TREAT-NMD international network to accelerate research and clinical trial recruitment.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 9 values shown
  • 5,500+ registrations since launch in 2007
+8 more records
Product overview1 text field

The Duchenne Registry is a patient-report registry platform for Duchenne and Becker muscular dystrophy and female carriers, accessible via a mobile app (iOS and Android) and web portal. Participants self-register and contribute longitudinal health data on topics including muscle strength, cardiac health, medications, and treatments. The Registry integrates with the Duchenne Outcomes Research Interchange, which combines patient-reported data with EHR data from participating Certified Duchenne Care Centers to create a comprehensive longitudinal natural history database. Supporting offerings include the Decode Duchenne free genetic testing program, and published research reports such as the 15 Year Registry Report.

Product and service3 records
1The Duchenne Registry (Mobile App and Web Portal)
CategoryPatient Registry Platform
Description

An online patient-reported registry for individuals with Duchenne or Becker muscular dystrophy and female carriers, accessible via mobile app (iOS and Android) and web portal. Participants self-register and contribute longitudinal health data on muscle strength, cardiac health, medications, and treatments to advance research and connect with clinical trials.

2Duchenne Outcomes Research Interchange
CategoryHealthcare Data Platform
Description

A patient- and clinician-reported data warehouse that combines patient-reported data from The Duchenne Registry with Electronic Health Record data and data from industry partners with approved therapies, managed by Prometheus Research (an IQVIA company). Provides a comprehensive longitudinal natural history database for Duchenne and Becker muscular dystrophy.

3PPMD's Electronic Health Record (EHR) Study
Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2019-01-01
Description

THREAD Research specializes in remote/virtual patient research. In 2019, The Duchenne Registry transitioned to a mobile app-based platform with THREAD Research. THREAD hosts the registry app and complies with important research and privacy regulations for protecting patient data. THREAD replaced participant names and personal information with codes for de-identification.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2018-01-01
Description

Prometheus Research (an IQVIA company) manages the Duchenne Outcomes Research Interchange, a secure data warehouse combining patient-reported registry data, EHR data, and data from industry partners. Prometheus are leaders in health data security and informatics. All data is stored securely in accordance with strict industry standards and patient privacy laws. The Interchange was launched in 2018.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2007-01-01
Description

The Duchenne Registry has been a member of the TREAT-NMD Neuromuscular Network since its inception in 2007. Several key data fields from The Duchenne Registry are shared with the TREAT-NMD International Neuromuscular Registry, which pools data from thousands of patients worldwide and enables more powerful data analysis and discovery. This partnership enhances global knowledge of Duchenne.

4Duchenne Regulatory Science Consortium (D-RSC)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

The Duchenne Registry contributes all de-identified data to D-RSC of the Critical Path Institute, who pools data from multiple sources to develop a Duchenne disease progression model. This partnership supports regulatory science and drug development for Duchenne therapies.

duchenneregistry.org
5PCORnet (Patient-Powered Research Networks)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

The Duchenne Registry was selected as a Patient-Powered Research Network (PPRN) in PCORnet for both Phase 1 and 2, from 2014-2019. This partnership connected the registry to a national patient-centered clinical research network.

duchenneregistry.org
Strategic tierMinorTypeStrategic or Co-development Partner
Description

PPMD and The Duchenne Registry partnered with pharmaceutical companies to launch and administer the Decode Duchenne free genetic testing program. Participants must be living in the United States or Canada. This program identifies individuals with dystrophinopathy and refers them to the registry.

7Certified Duchenne Care Centers (CDCCs)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

PPMD's Certified Duchenne Care Centers (CDCCs) are active partners with The Duchenne Registry. Their expert clinicians provide advice and guidance, and they encourage their patients and families to register. Some CDCCs have established EHR integration with the Duchenne Outcomes Research Interchange for the EHR Study.

duchenneregistry.org
8Duchenne Drug Development Roundtable (DDDR)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

PPMD's Duchenne Drug Development Roundtable (DDDR) of pharmaceutical partners provides valuable advice and guidance from the industry perspective. DDDR includes pharmaceutical companies developing Duchenne therapies.

duchenneregistry.org
Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

RTI International performed statistical analyses for the 10-year registry report, cleaning data and running analyses that were reviewed by the PPMD Registry team.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

duchenneconnect

Patient Registry Platformduchenneregistry.org

The Duchenne Registry is a free, patient-reported mobile and web registry for individuals with Duchenne and Becker muscular dystrophy and female carriers, operated by Parent Project Muscular Dystrophy since 2007 and combining 15 years of longitudinal self-reported data with EHR data from Certified Duchenne Care Centers.

What duchenneconnect does

DuchenneConnect (operating as The Duchenne Registry) is a nonprofit patient-reported registry founded in 2007 and operated by Parent Project Muscular Dystrophy (PPMD) that serves individuals with Duchenne and Becker muscular dystrophy, female carriers, and others with pathogenic Duchenne gene variants. Participants self-register through a mobile app (iOS and Android, launched 2019 via THREAD Research) and a web portal, then complete longitudinal surveys covering muscle strength, cardiac health, medications, and treatments. As of the 15-year report, the registry held approximately 5,500 registrants across more than 125 countries, with data used in 13+ peer-reviewed publications and connected to 175+ clinical trials and research studies.

The registry's core technology layer consists of three components: the THREAD Research-hosted mobile/web participant platform, the Prometheus Research (an IQVIA company)-managed Duchenne Outcomes Research Interchange data warehouse, and bidirectional EHR integration with PPMD's Certified Duchenne Care Centers (CDCCs). This architecture combines patient-reported data, clinical EHR data, and data from industry partners with approved therapies into a unified longitudinal natural history dataset. Data is also contributed to TREAT-NMD's international pooled registry and the Duchenne Regulatory Science Consortium (D-RSC) at the Critical Path Institute.

The business model is grant- and donation-funded rather than commercial. PPMD has been the sole institutional funder since 2011, covering all operating costs. Participation is free for patients and families, with no pricing tiers. De-identified data is shared with researchers and pharmaceutical companies on a research-collaboration basis rather than through paid licensing, although the registry reserves the right to charge for services in the future. The customer base is therefore split between patient/caregiver participants (no cost) and industry/academic data consumers (collaborative access), with the Duchenne Drug Development Roundtable (DDDR) serving as the industry advisory channel.

duchenneconnect firmographics

Firmographics
Name
duchenneconnect
Legal name
Parent Project Muscular Dystrophy
Website
https://duchenneregistry.org
Company type
Private
Founded year
2007
Operating status
Operating
Short description
The Duchenne Registry is a free, patient-reported mobile and web registry for individuals with Duchenne and Becker muscular dystrophy and female carriers, operated by Parent Project Muscular Dystrophy since 2007 and combining 15 years of longitudinal self-reported data with EHR data from Certified Duchenne Care Centers.
Ownership category
akta.pro rank

duchenneconnect industry classification

Industry
Product category
Patient Registry Platform
akta.pro industry
PRIMARYHLACAHAH
Patient Registries & Chronic Disease Registry Analytics
Healthcare & Life Sciences/Digital Health & Health IT/Population Health Management & Value-Based Care Analytics
SECONDARYHLAJAJAE
Disease Registries (Cancer, Immunization, Rare Disease, etc.)
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Statistics, Vital Records & Population Health Analytics

Keywords

  • Patient registry platform
  • Rare disease research
  • Clinical trial recruitment
  • Natural history data
  • Genetic testing program

Where duchenneconnect is headquartered

Location

Headquarters

HQ city
Hackensack
HQ country
United States
HQ region
North America

Offices1 record

Markets served

duchenneconnect business model

Business model
GTM type
B2C
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Research Grants and Institutional Funding: The Duchenne Registry has been funded entirely by Parent Project Muscular Dystrophy (PPMD) since 2011. PPMD funds the registry through institutional budgets and grants. Data is shared with researchers and pharmaceutical companies (de-identified) to advance Duchenne research. Participation is free for patients. Registry services are provided at no cost to registrants.
  2. Data Licensing to Industry Partners: De-identified registry data is shared with researchers, pharmaceutical companies, and the Duchenne Regulatory Science Consortium (D-RSC) at the Critical Path Institute to support drug development and clinical trials. This is done on a research collaboration basis, not a commercial transaction.

Pricing tiers

ModelBillingPrice
FreemiumFreeFree Patient Participation

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

duchenneconnect product offering

Product offering

Core offering

The Duchenne Registry is a patient-reported data registry for individuals with Duchenne or Becker muscular dystrophy and female carriers, accessible via mobile app (iOS and Android) and web portal. Participants self-register, complete medical surveys on muscle strength, cardiac health, medications, and treatments, and contribute longitudinal health data that is shared (de-identified) with researchers, drug developers, and the TREAT-NMD international network to accelerate research and clinical trial recruitment.

Product overview

The Duchenne Registry is a patient-report registry platform for Duchenne and Becker muscular dystrophy and female carriers, accessible via a mobile app (iOS and Android) and web portal. Participants self-register and contribute longitudinal health data on topics including muscle strength, cardiac health, medications, and treatments. The Registry integrates with the Duchenne Outcomes Research Interchange, which combines patient-reported data with EHR data from participating Certified Duchenne Care Centers to create a comprehensive longitudinal natural history database. Supporting offerings include the Decode Duchenne free genetic testing program, and published research reports such as the 15 Year Registry Report.

Differentiator

Problem solved

Functional benefit

Brands

  • Duchenne Outcomes Research Interchange: A patient- and clinician-reported data warehouse combining data from The Duchenne Registry with Electronic Health Record data and industry partner data.

Products and services

  • The Duchenne Registry (Mobile App and Web Portal) An online patient-reported registry for individuals with Duchenne or Becker muscular dystrophy and female carriers, accessible via mobile app (iOS and Android) and web portal. Participants self-register and contribute longitudinal health data on muscle strength, cardiac health, medications, and treatments to advance research and connect with clinical trials.
  • Duchenne Outcomes Research Interchange A patient- and clinician-reported data warehouse that combines patient-reported data from The Duchenne Registry with Electronic Health Record data and data from industry partners with approved therapies, managed by Prometheus Research (an IQVIA company). Provides a comprehensive longitudinal natural history database for Duchenne and Becker muscular dystrophy.
  • PPMD's Electronic Health Record (EHR) Study

Quantifiable outcome

  • 5,500+ registrations since launch in 2007
  • +8 more outcomes

Companies that use duchenneconnect

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles3 records

duchenneconnect technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

duchenneconnect partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and minor.

  • THREAD ResearchcoreTechnology or Integration · 1 January 2019THREAD Research specializes in remote/virtual patient research. In 2019, The Duchenne Registry transitioned to a mobile app-based platform with THREAD Research. THREAD hosts the registry app and complies with important research and privacy regulations for protecting patient data. THREAD replaced participant names and personal information with codes for de-identification.
  • Prometheus Research (IQVIA)coreTechnology or Integration · 1 January 2018Prometheus Research (an IQVIA company) manages the Duchenne Outcomes Research Interchange, a secure data warehouse combining patient-reported registry data, EHR data, and data from industry partners. Prometheus are leaders in health data security and informatics. All data is stored securely in accordance with strict industry standards and patient privacy laws. The Interchange was launched in 2018.
  • TREAT-NMD Neuromuscular NetworkcoreStrategic or Co-development Partner · 1 January 2007The Duchenne Registry has been a member of the TREAT-NMD Neuromuscular Network since its inception in 2007. Several key data fields from The Duchenne Registry are shared with the TREAT-NMD International Neuromuscular Registry, which pools data from thousands of patients worldwide and enables more powerful data analysis and discovery. This partnership enhances global knowledge of Duchenne.
  • Duchenne Regulatory Science Consortium (D-RSC)coreStrategic or Co-development PartnerThe Duchenne Registry contributes all de-identified data to D-RSC of the Critical Path Institute, who pools data from multiple sources to develop a Duchenne disease progression model. This partnership supports regulatory science and drug development for Duchenne therapies.
  • PCORnet (Patient-Powered Research Networks)minorStrategic or Co-development PartnerThe Duchenne Registry was selected as a Patient-Powered Research Network (PPRN) in PCORnet for both Phase 1 and 2, from 2014-2019. This partnership connected the registry to a national patient-centered clinical research network.
  • Decode Duchenne Program PartnersminorStrategic or Co-development PartnerPPMD and The Duchenne Registry partnered with pharmaceutical companies to launch and administer the Decode Duchenne free genetic testing program. Participants must be living in the United States or Canada. This program identifies individuals with dystrophinopathy and refers them to the registry.
  • Certified Duchenne Care Centers (CDCCs)coreStrategic or Co-development PartnerPPMD's Certified Duchenne Care Centers (CDCCs) are active partners with The Duchenne Registry. Their expert clinicians provide advice and guidance, and they encourage their patients and families to register. Some CDCCs have established EHR integration with the Duchenne Outcomes Research Interchange for the EHR Study.
  • Duchenne Drug Development Roundtable (DDDR)minorStrategic or Co-development PartnerPPMD's Duchenne Drug Development Roundtable (DDDR) of pharmaceutical partners provides valuable advice and guidance from the industry perspective. DDDR includes pharmaceutical companies developing Duchenne therapies.
  • RTI International Center for Newborn Screening, Ethics, and Disability StudiesminorImplementation/ SI/ Consulting PartnerRTI International performed statistical analyses for the 10-year registry report, cleaning data and running analyses that were reviewed by the PPMD Registry team.

Scale indicators10 records

Recent moves6 records

Expansion highlights5 records

duchenneconnect competitors and assessment

Company assessment

Market position

Strengths5 records

Weaknesses3 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

duchenneconnect financial estimates

Financial estimate

Revenue estimate

Valuation estimate

duchenneconnect leadership team

Management profile

Number of profiles

Profiles6 records

duchenneconnect funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

duchenneconnect M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about duchenneconnect

What does duchenneconnect do?

The Duchenne Registry is a patient-reported data registry for individuals with Duchenne or Becker muscular dystrophy and female carriers, accessible via mobile app (iOS and Android) and web portal. Participants self-register, complete medical surveys on muscle strength, cardiac health, medications, and treatments, and contribute longitudinal health data that is shared (de-identified) with researchers, drug developers, and the TREAT-NMD international network to accelerate research and clinical trial recruitment.

Is duchenneconnect a public or private company?

duchenneconnect is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was duchenneconnect founded?

duchenneconnect was founded in 2007.

Where is duchenneconnect based?

duchenneconnect is headquartered in Hackensack, United States, in the North America region.

How does duchenneconnect make money?

Two revenue lines are on record. Research Grants and Institutional Funding is the primary driver. The others are data Licensing to Industry Partners.

Does duchenneconnect have an API?

No public API is recorded for duchenneconnect.

What industry is duchenneconnect in?

duchenneconnect's product category is Patient Registry Platform. Its primary akta.pro industry code is HLACAHAH, Patient Registries & Chronic Disease Registry Analytics, with a secondary code of HLAJAJAE, Disease Registries (Cancer, Immunization, Rare Disease, etc.).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals